The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3E,5E)-3-(3-pyridylmethylene)-5-(2-trifluoromethylbenzylidene)-1-((4-bromophenyl)sulfonyl)piperidin-4-one ID: ALA4483682
PubChem CID: 155540631
Max Phase: Preclinical
Molecular Formula: C25H18BrF3N2O3S
Molecular Weight: 563.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2cccnc2)CN(S(=O)(=O)c2ccc(Br)cc2)C/C1=C\c1ccccc1C(F)(F)F
Standard InChI: InChI=1S/C25H18BrF3N2O3S/c26-21-7-9-22(10-8-21)35(33,34)31-15-19(12-17-4-3-11-30-14-17)24(32)20(16-31)13-18-5-1-2-6-23(18)25(27,28)29/h1-14H,15-16H2/b19-12+,20-13+
Standard InChI Key: NFPGUJRKFSZKRY-KVOOEGMKSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
24.9965 -7.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7022 -7.2857 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.2868 -7.2926 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.9913 -6.8803 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.9996 -8.5147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9928 -10.9660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1756 -10.9660 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.5842 -11.6738 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6413 -8.9395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6401 -9.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3482 -10.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0578 -9.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0550 -8.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3464 -8.5307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7612 -8.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4704 -8.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4709 -9.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1761 -10.1509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8847 -9.7431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8835 -8.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1738 -8.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1698 -7.6974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5911 -8.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2990 -8.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2945 -9.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0016 -10.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7101 -9.7407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7072 -8.9193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4684 -11.3766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7641 -10.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0569 -11.3717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0565 -12.1898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7691 -12.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4735 -12.1880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3493 -12.5993 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 1 0
1 3 1 0
1 4 1 0
7 6 2 0
8 7 2 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
15 16 2 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
20 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 5 2 0
5 24 1 0
18 7 1 0
7 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
32 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 563.40Molecular Weight (Monoisotopic): 562.0174AlogP: 5.60#Rotatable Bonds: 4Polar Surface Area: 67.34Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.82CX LogP: 5.55CX LogD: 5.55Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: -1.28
References 1. Yao BR, Sun Y, Chen SL, Suo HD, Zhang YL, Wei H, Wang CH, Zhao F, Cong W, Xin WY, Hou GG.. (2019) Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation., 167 [PMID:30771605 ] [10.1016/j.ejmech.2019.02.020 ]